−46.8
Enliven Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−32.1
FY23:
−61.3
FY24:
−73.2
FY25:
−70.3
Change from FY21 to FY25
millions USD
FY21:
−1.63
FY22:
−0.61
FY23:
−148
FY24:
−36.0
FY25:
−174
Change from FY21 to FY25
millions USD
FY21:
49.1
FY22:
−1.80
FY23:
234
FY24:
133
FY25:
219
(positive)
Change from FY21 to FY25
millions USD
FY21:
−46.8
FY22:
−32.7
FY23:
−61.4
FY24:
−73.2
FY25:
−70.5
All amounts in millions USD